Proteins For Sale

Vascular Endothelial Growth Inhibitor (VEGI)

Blocking or inhibiting blood vessel growth (angiogenesis) remains a critical focal point for anticancer drug development. Vascular Endothelial Growth Inhibitor (VEGI; TNFSF-15) is a cytokine secreted from human endothelial cells and a potent negative regulator of angiogenesis that induces growth arrest and apoptosis in endothelial cells. We are developing VEGI as an anti-cancer drug candidate. Besides internal use, we are also providing highly active VEGI proteins to the research community.

For pricing and other information, please contact zhu at proteomtech-inc.com.

Reference:
VEGI-192, a New Isoform of TNFSF15, Specifically Eliminates Tumor Vascular Endothelial Cells and Suppresses Tumor Growth
Wen Hou1, Dan Medynski2, Shirley Wu2, Xinli Lin2 and Lu-Yuan Li1
Authors' Affiliations: 1 Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania and 2 ProteomTech, Inc., Emeryville, California
Clinical Cancer Research Vol. 11, 5595-5602, August 1, 2005

« Back to Proteins For Sale List

 
FOR SALE: Difficult and Medically Important Proteins

FOR SALE: Difficult and
Medically Important Proteins.

BREAKING NEWS:
ProteomTech, Inc. and
Collaborators Make Major Breakthrough
in Stem Cell Research

View a technical animation about our high throughput protein refolding technology.

View a technical animation about our high throughput protein refolding technology.

Quicktime | Win Media
Find out why many top pharmaceutical companies are working with us

Find out why many top
pharmaceutical companies are working with us.